CareDx (CDNA) Launches AI-based Platform VANTx

CareDx, Inc. (NASDAQ:CDNA) is 1 of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts.

On March 5, 2026, CareDx, Inc. (NASDAQ:CDNA) launched VANTx, an AI-powered, cloud-native level designed to alteration analyzable transplant information into actionable objective insights. The platform, introduced astatine the 2026 Precision Medicine World Conference, analyzes diligent cohorts, attraction trends, and real-world grounds with the assistance of Llama 3 and precocious instrumentality learning. Jing Huang, Chief Data and AI Officer astatine CareDx, Inc. (NASDAQ:CDNA), gave the pursuing statement.

As the marketplace person successful transplant precision diagnostics and diligent attraction solutions, we tin assistance our transplant halfway partners make actionable insights utilizing LLMs and different models.

The level is initially disposable via aesculapian consultation, with plans to rotation retired permission-based entree to clinicians further into 2026.

Separately, connected February 26, 2026, BTIG raised its terms people connected CareDx, Inc. (NASDAQ:CDNA) from $25 to $26 portion maintaining a Buy standing connected the company’s stock. The steadfast cited affirmative Q4 results and 2026 gross guidance supra thoroughfare estimates, portion acknowledging the breadth of the range.

Founded successful 1998, CareDx, Inc. (NASDAQ:CDNA) is simply a transplant diagnostics institution that provides high-value diagnostic surveillance solutions. Its office is successful California.

While we admit the imaginable of CDNA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Stocks to Invest successful During a Recession and 10 Best Space Exploration Stocks to Buy According to Analysts

Disclosure: None. Follow Insider Monkey connected Google News.